
Ketohexokinase Inhibitor Improved Liver Health
A six-week study found that the drug PF-06835919 enhanced insulin sensitivity in patients with steatotic liver disease.

A six-week study found that the drug PF-06835919 enhanced insulin sensitivity in patients with steatotic liver disease.
October 7, 2026
Experimental Drug Reduced Visceral Fat in Human TrialsResearchers found that the drug CBL-514 successfully decreased hidden abdominal fat in a recent phase 2 study.
October 7, 2026
World Health Organization Opposed Pediatric Obesity DrugsThe health body cautioned against using weight loss medications for children under 10 years old.
October 6, 2026
Semaglutide Reduced Liver Fat in Obesity PatientsA new analysis showed significant reductions in liver fat for adults with obesity after taking semaglutide.
October 5, 2026
Ultrasound Metrics Linked to Cell Size in LymphedemaA study published on October 5, 2026, revealed correlations between ultrasound tissue grades and adipocyte area.
October 4, 2026
Brooks Nader Disclosed GLP-1 Weight Loss UseThe 29-year-old model recently shared her use of GLP-1 medication to lose 30 pounds for modeling work.
October 4, 2026
Marley Spoon Launched Meal Kits for GLP-1 UsersThe company introduced a specialized product line to combat declining sales following a 15 percent revenue drop.
October 2, 2026
Developer Released cvELD Edit Paint Add-on for BlenderThe new tool introduces advanced weight painting capabilities for Blender users across multiple bone structures.
October 1, 2026
Survodutide Trial Resulted in Significant Weight LossBoehringer Ingelheim released Phase III clinical trial data showing notable weight reduction for patients with type 2 diabetes.
October 1, 2026
MRI Research Linked Muscle Composition to MortalityNew research suggests that muscle fat and volume provide health insights beyond standard weight measurements.
September 30, 2026
Polar Released Polar OS6 Software UpdateThe update brings new weight tracking features and battery management to six watch models.